Shina Lee
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Shina Lee has a total of 30 co-authors. Here are the top co-authors by number of shared publications:
Seung-Jung Kim
Department of Internal Medicine, School of Medicine, Ewha Womans University, Seoul, South Korea
3 shared publicationsKyu Bok Choi
Department of Internal Medicine, School of Medicine, Ewha Womans University, Seoul, Korea
2 shared publications- Seung-Jung Kim
Department of Nephrology, Ewha Womans University College of Medicine, Seoul, Korea
2 shared publications - Dong-Ryeol Ryu
Department of Internal Medicine, Ewha Womans University College of Medicine, Seoul, Republic of Korea
1 shared publication Duk-Hee Kang
Department of Internal Medicine, School of Medicine, Ewha Womans University, Seoul, Korea
1 shared publication- Duk-Hee Kang
Division of Nephrology, Department of Internal Medicine, Ewha Womans University School of Medicine, Ewha Medical Research Center, Seoul, Republic of Korea
1 shared publication
Latest Publications
- 25 March 2026
- Published by The Korean Society of Nephrology in Kidney Research and Clinical Practice
p-Cresyl sulfate promotes smooth muscle cell proliferation and endothelial dysfunction, leading to development of neointimal hyperplasia
Vascular access failure is a major cause of morbidity in hemodialysis patients, primarily driven by smooth muscle cell (SMC) proliferation-related neointimal hyperplasia. The uremic toxin p-cresyl sulfate (p-CS) has been linked to poor vascular access outcomes, but its pathogenic mechanisms remain unclear. This study investigated whether p-CS promotes SMC proliferation and induces endothelial dysfunction, and contributes to neointimal hyperplasia. Human aortic SMCs were treated with p-CS to assess proliferation and activation of ERK1/2 and p38 MAPK signaling. In human umbilical vein endothelial cells (HUVECs), oxidative stress and expression of inflammatory mediators (NF-κB, ICAM-1, MCP-1) were measured at mRNA and protein levels, along with eNOS and iNOS expression. A Transwell co-culture system was used to evaluate whether p-CS-induced endothelial alterations affect SMC proliferation. Neointimal formation after p-CS exposure was confirmed using an ex vivo mouse aorta model. p-CS promoted SMC proliferation in a dose-dependent manner and activated ERK1/2 and p38 MAPK. In HUVECs, p-CS induced ROS generation and increased NF-κB, ICAM-1, and MCP-1 expression, while upregulating iNOS and suppressing eNOS. In co-culture, p-CS-stimulated HUVECs enhanced SMC proliferation; this effect was attenuated by NAC, probenecid, or neutralizing antibodies against MCP-1 and ICAM-1. In the ex vivo aorta model, p-CS induced neointimal hyperplasia accompanied by elevated α-SMA, ICAM-1, and MCP-1 expression. These findings suggest that p-CS may promote SMC proliferation both directly and indirectly through endothelial dysfunction, ultimately contributing to neointimal hyperplasia. Further studies are needed to clarify the clinical implications of p-CS in vascular access dysfunction.
- 25 March 2026
- Published by The Korean Society of Nephrology in Kidney Research and Clinical Practice
p-Cresyl sulfate promotes smooth muscle cell proliferation and endothelial dysfunction, leading to development of neointimal hyperplasia
Vascular access failure is a major cause of morbidity in hemodialysis patients, primarily driven by smooth muscle cell (SMC) proliferation-related neointimal hyperplasia. The uremic toxin p-cresyl sulfate (p-CS) has been linked to poor vascular access outcomes, but its pathogenic mechanisms remain unclear. This study investigated whether p-CS promotes SMC proliferation and induces endothelial dysfunction, and contributes to neointimal hyperplasia. Human aortic SMCs were treated with p-CS to assess proliferation and activation of ERK1/2 and p38 MAPK signaling. In human umbilical vein endothelial cells (HUVECs), oxidative stress and expression of inflammatory mediators (NF-κB, ICAM-1, MCP-1) were measured at mRNA and protein levels, along with eNOS and iNOS expression. A Transwell co-culture system was used to evaluate whether p-CS-induced endothelial alterations affect SMC proliferation. Neointimal formation after p-CS exposure was confirmed using an ex vivo mouse aorta model. p-CS promoted SMC proliferation in a dose-dependent manner and activated ERK1/2 and p38 MAPK. In HUVECs, p-CS induced ROS generation and increased NF-κB, ICAM-1, and MCP-1 expression, while upregulating iNOS and suppressing eNOS. In co-culture, p-CS-stimulated HUVECs enhanced SMC proliferation; this effect was attenuated by NAC, probenecid, or neutralizing antibodies against MCP-1 and ICAM-1. In the ex vivo aorta model, p-CS induced neointimal hyperplasia accompanied by elevated α-SMA, ICAM-1, and MCP-1 expression. These findings suggest that p-CS may promote SMC proliferation both directly and indirectly through endothelial dysfunction, ultimately contributing to neointimal hyperplasia. Further studies are needed to clarify the clinical implications of p-CS in vascular access dysfunction.
- Open Access
- 1 January 2026
- Published by XMLink in Electrolytes & Blood Pressure
- Vol. 24 (3) , 175-188
Impact of the Four Pillars on Electrolyte Derangements during State-of-the-Art Therapy for Diabetic Kidney Disease
Yoo MJ, et al. Electrolyte Blood Press. 2026 Sep;24(3):175-188. https://doi.org/10.5049/EBP.2026.24.e13
- 1 January 2026
- Published by XMLink in Electrolytes & Blood Pressure
- Vol. 24 (3) , 175-188
Open AccessImpact of the Four Pillars on Electrolyte Derangements during State-of-the-Art Therapy for Diabetic Kidney Disease
Yoo MJ, et al. Electrolyte Blood Press. 2026 Sep;24(3):175-188. https://doi.org/10.5049/EBP.2026.24.e13
- Open Access
- 31 May 2024
- Published by Wolters Kluwer Health in Medicine
- Vol. 103 (22) , e38408
Progressive increase in vascular access blood flow after percutaneous transluminal angioplasty in patients on hemodialysis
Percutaneous transluminal angioplasty (PTA) is the gold standard for treating stenoses with dysfunctional vascular access. Recently, we found that vascular access blood flow (VABF) measured immediately after PTA increased over time without the need for additional procedures in the patients who underwent PTA. Therefore, this study was conducted to confirm an increase in VABF after PTA and identify the factors associated with it. Patients on chronic hemodialysis at a single institution were retrospectively reviewed and those with accesses that had a measurement of VABF immediately after PTA and within 1 month from PTA were included in the study. The relationship between clinical parameters and changes in VABF were analyzed using paired t-test and linear regression. A total of 47 PTA accesses (fistulas, 26; grafts,21) were included. The mean VABF on the day of PTA and the following measurement were 796.9 ± 329.1 mL/min and 1105.1 ± 410.3 mL/min, respectively. In the univariate analysis, the diameter of the balloon catheter used in the PTA and serum uric acid (SUA) level were significantly associated with an increase in VABF. Atrial fibrillation was a significant factor for the percentage change in vascular access. In the multivariate analysis, SUA level, balloon catheter diameter, and atrial fibrillation remained independent factors for changes in VABF and percentage change in VABF, respectively. The study identified progressive increases in the VABF after PTA without additional procedures. SUA level, balloon catheter diameter used in PTA, and atrial fibrillation were independently associated with changes in VABF.
- 31 May 2024
- Published by Wolters Kluwer Health in Medicine
- Vol. 103 (22) , e38408
Open AccessProgressive increase in vascular access blood flow after percutaneous transluminal angioplasty in patients on hemodialysis
Percutaneous transluminal angioplasty (PTA) is the gold standard for treating stenoses with dysfunctional vascular access. Recently, we found that vascular access blood flow (VABF) measured immediately after PTA increased over time without the need for additional procedures in the patients who underwent PTA. Therefore, this study was conducted to confirm an increase in VABF after PTA and identify the factors associated with it. Patients on chronic hemodialysis at a single institution were retrospectively reviewed and those with accesses that had a measurement of VABF immediately after PTA and within 1 month from PTA were included in the study. The relationship between clinical parameters and changes in VABF were analyzed using paired t-test and linear regression. A total of 47 PTA accesses (fistulas, 26; grafts,21) were included. The mean VABF on the day of PTA and the following measurement were 796.9 ± 329.1 mL/min and 1105.1 ± 410.3 mL/min, respectively. In the univariate analysis, the diameter of the balloon catheter used in the PTA and serum uric acid (SUA) level were significantly associated with an increase in VABF. Atrial fibrillation was a significant factor for the percentage change in vascular access. In the multivariate analysis, SUA level, balloon catheter diameter, and atrial fibrillation remained independent factors for changes in VABF and percentage change in VABF, respectively. The study identified progressive increases in the VABF after PTA without additional procedures. SUA level, balloon catheter diameter used in PTA, and atrial fibrillation were independently associated with changes in VABF.
- Open Access
- 13 September 2022
- Published by XMLink in Korean Journal of Radiology
- Vol. 23 (10) , 949-958
Feasibility of Deep Learning-Based Analysis of Auscultation for Screening Significant Stenosis of Native Arteriovenous Fistula for Hemodialysis Requiring Angioplasty
Park JH, et al. Korean J Radiol. 2022 Oct;23(10):949-958. https://doi.org/10.3348/kjr.2022.0364
- 13 September 2022
- Published by XMLink in Korean Journal of Radiology
- Vol. 23 (10) , 949-958
Open AccessFeasibility of Deep Learning-Based Analysis of Auscultation for Screening Significant Stenosis of Native Arteriovenous Fistula for Hemodialysis Requiring Angioplasty
Park JH, et al. Korean J Radiol. 2022 Oct;23(10):949-958. https://doi.org/10.3348/kjr.2022.0364
- Open Access
- 12 July 2022
- Published by Frontiers Media SA in Frontiers in Medicine
- Vol. 9, 935977
Effects of Normal Reference Range of Phosphorus and Corresponding PTH on Endothelial Function in CKD Patients
Introduction: Endothelial dysfunction commonly occurs in chronic kidney disease (CKD) patients and increases the risk for cardiovascular disease. Among CKD patients, biomarkers involved in the pathogenesis of CKD-mineral bone disorder (CKD-MBD), such as phosphorus, parathyroid hormone, and fibroblast growth factor 23, are associated with endothelial dysfunction. We investigated whether these biomarkers induce endothelial dysfunction in CKD patients with normal phosphorus levels.Methods: This cross-sectional study examined CKD patients with normal phosphorus levels; patients with an estimated glomerular filtration rate (eGFR) r = 0.22, P = 0.04), intact parathyroid hormone (iPTH; r = −0.46, P < 0.01), and VCAM-1 (r = −0.36, P < 0.01). The reactive hyperemia index (RHI) was significantly related to phosphorus levels (r = 0.32, P < 0.01) and iPTH (r = −0.39, P = 0.02). After adjusting for eGFR, iPTH and VCAM-1 remained independent factors for predicting endothelial dysfunction measured using Ach-induced ILDF. In addition, iPTH and phosphorus levels were independent predictors for endothelial dysfunction measured using RHI in the eGFR-adjusted model. Mediation analyses showed that the individual indirect effects of iPTH were significantly affected ILDF and RHI.Conclusion: Serum levels of phosphorus and iPTH are associated with endothelial dysfunction, even in CKD patients with normal phosphorus levels.
- 12 July 2022
- Published by Frontiers Media SA in Frontiers in Medicine
- Vol. 9, 935977
Open AccessEffects of Normal Reference Range of Phosphorus and Corresponding PTH on Endothelial Function in CKD Patients
Introduction: Endothelial dysfunction commonly occurs in chronic kidney disease (CKD) patients and increases the risk for cardiovascular disease. Among CKD patients, biomarkers involved in the pathogenesis of CKD-mineral bone disorder (CKD-MBD), such as phosphorus, parathyroid hormone, and fibroblast growth factor 23, are associated with endothelial dysfunction. We investigated whether these biomarkers induce endothelial dysfunction in CKD patients with normal phosphorus levels.Methods: This cross-sectional study examined CKD patients with normal phosphorus levels; patients with an estimated glomerular filtration rate (eGFR) r = 0.22, P = 0.04), intact parathyroid hormone (iPTH; r = −0.46, P < 0.01), and VCAM-1 (r = −0.36, P < 0.01). The reactive hyperemia index (RHI) was significantly related to phosphorus levels (r = 0.32, P < 0.01) and iPTH (r = −0.39, P = 0.02). After adjusting for eGFR, iPTH and VCAM-1 remained independent factors for predicting endothelial dysfunction measured using Ach-induced ILDF. In addition, iPTH and phosphorus levels were independent predictors for endothelial dysfunction measured using RHI in the eGFR-adjusted model. Mediation analyses showed that the individual indirect effects of iPTH were significantly affected ILDF and RHI.Conclusion: Serum levels of phosphorus and iPTH are associated with endothelial dysfunction, even in CKD patients with normal phosphorus levels.
- Open Access
- 14 March 2022
- Published by Springer Nature in BMC Nephrology
- Vol. 23 (1) , 1-11
Early fluid management affects short-term mortality in patients with end-stage kidney disease undergoing chronic hemodialysis and requiring continuous renal replacement therapy
Background: Early fluid management is considered a key element affecting mortality in critically ill patients requiring continuous renal replacement therapy (CRRT). Most studies have primarily focused on patients with intrinsic acute kidney injury requiring CRRT, although end-stage kidney disease (ESKD) patients generally exhibit greater vulnerability. We investigated the association between fluid balance and short-term mortality outcomes in ESKD patients undergoing chronic hemodialysis and requiring CRRT. Methods: This retrospective study included 110 chronic hemodialysis patients who received CRRT between 2017 and 2019 at Ewha Womans University Mokdong Hospital. The amounts of daily input and output, and cumulative 3-day and 7-day input and output, were assessed from the initiation of CRRT. The participants were classified into two groups based on 7-day and 14-day mortalities. Cox regression analyses were carried out on the basis of the amounts of daily input and output, cumulative input and output, and cumulative fluid balance. Results: During follow-up, 7-day and 14-day mortalities were observed in 24 (21.8%) and 34 (30.9%) patients. The patients were stratified into two groups (14-day survivors vs. non-survivors), and there were no significant differences in demographic characteristics between the two groups. However, diabetes mellitus was more common among survivors than among non-survivors. Univariate analyses showed that the amounts of daily output at 48, and 72 h, and 3-day cumulative input and output, were significantly associated with 7-day mortality risk regardless of the cumulative fluid balance (HR: 0.28, 95% CI: 0.12–0.70, p = 0.01 for daily output at 48 h; HR: 0.34, 95% CI: 0.13–0.85, p = 0.02 for daily output at 72 h.; HR: 0.72, 95% CI: 0.61–0.86, p = 0.01 for 3-day cumulative input; HR: 0.65, 95% CI: 0.41–0.90, p = 0.01 for 3-day cumulative output). Adjusted multivariate analyses showed that the lower 3-day cumulative output is an independent risk factor for 7-day and 14-day mortality. Conclusions: In our study, increased cumulative output were significantly associated with reduced short-term mortality risk in chronic hemodialysis patients undergoing CRRT regardless of cumulative fluid balance. Further prospective studies to investigate the association between fluid balance and mortality in ESRD patients requiring CRRT are warranted.
- 14 March 2022
- Published by Springer Nature in BMC Nephrology
- Vol. 23 (1) , 1-11
Open AccessEarly fluid management affects short-term mortality in patients with end-stage kidney disease undergoing chronic hemodialysis and requiring continuous renal replacement therapy
Background: Early fluid management is considered a key element affecting mortality in critically ill patients requiring continuous renal replacement therapy (CRRT). Most studies have primarily focused on patients with intrinsic acute kidney injury requiring CRRT, although end-stage kidney disease (ESKD) patients generally exhibit greater vulnerability. We investigated the association between fluid balance and short-term mortality outcomes in ESKD patients undergoing chronic hemodialysis and requiring CRRT. Methods: This retrospective study included 110 chronic hemodialysis patients who received CRRT between 2017 and 2019 at Ewha Womans University Mokdong Hospital. The amounts of daily input and output, and cumulative 3-day and 7-day input and output, were assessed from the initiation of CRRT. The participants were classified into two groups based on 7-day and 14-day mortalities. Cox regression analyses were carried out on the basis of the amounts of daily input and output, cumulative input and output, and cumulative fluid balance. Results: During follow-up, 7-day and 14-day mortalities were observed in 24 (21.8%) and 34 (30.9%) patients. The patients were stratified into two groups (14-day survivors vs. non-survivors), and there were no significant differences in demographic characteristics between the two groups. However, diabetes mellitus was more common among survivors than among non-survivors. Univariate analyses showed that the amounts of daily output at 48, and 72 h, and 3-day cumulative input and output, were significantly associated with 7-day mortality risk regardless of the cumulative fluid balance (HR: 0.28, 95% CI: 0.12–0.70, p = 0.01 for daily output at 48 h; HR: 0.34, 95% CI: 0.13–0.85, p = 0.02 for daily output at 72 h.; HR: 0.72, 95% CI: 0.61–0.86, p = 0.01 for 3-day cumulative input; HR: 0.65, 95% CI: 0.41–0.90, p = 0.01 for 3-day cumulative output). Adjusted multivariate analyses showed that the lower 3-day cumulative output is an independent risk factor for 7-day and 14-day mortality. Conclusions: In our study, increased cumulative output were significantly associated with reduced short-term mortality risk in chronic hemodialysis patients undergoing CRRT regardless of cumulative fluid balance. Further prospective studies to investigate the association between fluid balance and mortality in ESRD patients requiring CRRT are warranted.
- Open Access
- 27 May 2020
- Published by Springer Nature in BMC Cardiovascular Disorders
- Vol. 20 (1) , 1-9
The effect of uric acid and urinary sodium excretion on prehypertension: a nationwide population-based study
Background: This study examined the effect of serum uric acid (SUA) level and urinary sodium excretion on blood pressure as well as their combined effect on prehypertension in a Korean population. Method: Data from the 7th Korea National Health and Nutrition Examination Survey for adults (≥ 19 years of age) were used. The participants were classified into two groups, normotension and prehypertension, according to the JNC-7 definition. Logistic regression was carried out and adjusted for traditionally regarded confounders of blood pressure. All analyses considered a complex sampling design. A multivariate analysis was performed on subgroups defined according to their SUA level and urinary sodium excretion. Results: The 4200 participants were divided into normotension (n = 2646) and prehypertension (n = 1554) groups. In the univariate analysis, patient age, male sex, concurrent comorbidity (diabetes mellitus, cardiovascular disease, stroke, dyslipidemia, and chronic kidney disease), uric acid, and urinary sodium excretion were associated with prehypertension. After adjusting for baseline covariates, both the SUA level and urinary sodium excretion were significant predictors of incident prehypertension (SUA, per 1 mg/dL increase, odds ratio [OR] 1.216, 95% confidence interval [95% CI] 1.131–1.309; urinary sodium excretion, per 1 g/day increase, OR 1.067, 95% CI 1.019–1.117). Additionally, simultaneously higher tertiles of SUA and urinary sodium excretion resulted in higher ORs for prehypertension. Conclusion: Increased SUA is a significant risk marker for the development of prehypertension in normotensives. Simultaneously high SUA and urinary sodium excretion amplified the effect on the development of prehypertension. Our findings suggest that lowering SUA levels and reducing sodium intake will contribute to preventing hypertension.
- 27 May 2020
- Published by Springer Nature in BMC Cardiovascular Disorders
- Vol. 20 (1) , 1-9
Open AccessThe effect of uric acid and urinary sodium excretion on prehypertension: a nationwide population-based study
Background: This study examined the effect of serum uric acid (SUA) level and urinary sodium excretion on blood pressure as well as their combined effect on prehypertension in a Korean population. Method: Data from the 7th Korea National Health and Nutrition Examination Survey for adults (≥ 19 years of age) were used. The participants were classified into two groups, normotension and prehypertension, according to the JNC-7 definition. Logistic regression was carried out and adjusted for traditionally regarded confounders of blood pressure. All analyses considered a complex sampling design. A multivariate analysis was performed on subgroups defined according to their SUA level and urinary sodium excretion. Results: The 4200 participants were divided into normotension (n = 2646) and prehypertension (n = 1554) groups. In the univariate analysis, patient age, male sex, concurrent comorbidity (diabetes mellitus, cardiovascular disease, stroke, dyslipidemia, and chronic kidney disease), uric acid, and urinary sodium excretion were associated with prehypertension. After adjusting for baseline covariates, both the SUA level and urinary sodium excretion were significant predictors of incident prehypertension (SUA, per 1 mg/dL increase, odds ratio [OR] 1.216, 95% confidence interval [95% CI] 1.131–1.309; urinary sodium excretion, per 1 g/day increase, OR 1.067, 95% CI 1.019–1.117). Additionally, simultaneously higher tertiles of SUA and urinary sodium excretion resulted in higher ORs for prehypertension. Conclusion: Increased SUA is a significant risk marker for the development of prehypertension in normotensives. Simultaneously high SUA and urinary sodium excretion amplified the effect on the development of prehypertension. Our findings suggest that lowering SUA levels and reducing sodium intake will contribute to preventing hypertension.
- Open Access
- 29 October 2019
- Published by Springer Nature in Critical Care
- Vol. 23 (1) , 1-11
The interactive effects of input and output on managing fluid balance in patients with acute kidney injury requiring continuous renal replacement therapy
The interactive effect of cumulative input and output on achieving optimal fluid balance has not been well elucidated in patients with acute kidney injury (AKI) requiring continuous renal replacement therapy (CRRT). This study evaluated the interrelation of fluid components with mortality in patients with AKI requiring CRRT. This is a retrospective observational study conducted with a total of 258 patients who were treated with CRRT due to AKI between 2016 and 2018 in the intensive care unit of Ewha Womans University Mokdong Hospital. The amounts of fluid input and output were assessed at 24-h and 72-h from the initiation of CRRT. The study endpoints were 7- and 28-day all-cause mortality. The mean patient age was 64.7 ± 15.8 years, and 165 (64.0%) patients were male. During the follow-up, 7- and 28-day mortalities were observed in 120 (46.5%) and 157 (60.9%) cases. The patients were stratified into two groups (28-day survivors vs. non-survivors), and the cumulative fluid balances (CFBs) at 24 h and 72 h were significantly higher in the 28-day non-survivors compared with the survivors. The increase in 24-h and 72-h CFB was significantly associated with an increase in 7- and 28-day mortality risks. To examine the interactive effect of cumulative input or output on the impact of CFB on mortality, we also stratified patients into three groups based on the tertile of 24-h and 72-h cumulative input or output. The increases in 24-h and 72-h CFBs were still significantly related to the increases in 7-day and 28-day mortality, irrespective of the cumulative input. However, we did not find significant associations between increase in 24-h and 72-h CFB and increase in mortality risk in the groups according to cumulative output tertile. The impact of cumulative fluid balance on mortality might be more dependent on cumulative output. The physicians need to decrease the cumulative fluid balance of CRRT patients as much as possible and consider increasing patient removal.
- 29 October 2019
- Published by Springer Nature in Critical Care
- Vol. 23 (1) , 1-11
Open AccessThe interactive effects of input and output on managing fluid balance in patients with acute kidney injury requiring continuous renal replacement therapy
The interactive effect of cumulative input and output on achieving optimal fluid balance has not been well elucidated in patients with acute kidney injury (AKI) requiring continuous renal replacement therapy (CRRT). This study evaluated the interrelation of fluid components with mortality in patients with AKI requiring CRRT. This is a retrospective observational study conducted with a total of 258 patients who were treated with CRRT due to AKI between 2016 and 2018 in the intensive care unit of Ewha Womans University Mokdong Hospital. The amounts of fluid input and output were assessed at 24-h and 72-h from the initiation of CRRT. The study endpoints were 7- and 28-day all-cause mortality. The mean patient age was 64.7 ± 15.8 years, and 165 (64.0%) patients were male. During the follow-up, 7- and 28-day mortalities were observed in 120 (46.5%) and 157 (60.9%) cases. The patients were stratified into two groups (28-day survivors vs. non-survivors), and the cumulative fluid balances (CFBs) at 24 h and 72 h were significantly higher in the 28-day non-survivors compared with the survivors. The increase in 24-h and 72-h CFB was significantly associated with an increase in 7- and 28-day mortality risks. To examine the interactive effect of cumulative input or output on the impact of CFB on mortality, we also stratified patients into three groups based on the tertile of 24-h and 72-h cumulative input or output. The increases in 24-h and 72-h CFBs were still significantly related to the increases in 7-day and 28-day mortality, irrespective of the cumulative input. However, we did not find significant associations between increase in 24-h and 72-h CFB and increase in mortality risk in the groups according to cumulative output tertile. The impact of cumulative fluid balance on mortality might be more dependent on cumulative output. The physicians need to decrease the cumulative fluid balance of CRRT patients as much as possible and consider increasing patient removal.